You are here

Category
Technology Name
Briefcase
Scientist
1482
Modification of the electronic properties of layered-type semiconductors can be accomplished by doping/alloying of the semiconductor. In the present disclosure we show that doping of MoS2 and WS2 nanotubes/nanoparticles can be accomplished by doping with either Re (n-type) or Nb (p-type) foreign atoms...

Modification of the electronic properties of layered-type semiconductors can be accomplished by doping/alloying of the semiconductor. In the present disclosure we show that doping of MoS2 and WS2 nanotubes/nanoparticles can be accomplished by doping with either Re (n-type) or Nb (p-type) foreign atoms. These nanoparticles combine both superior mechanical properties and high electrical conductivity.

The main market for these kinds of nanoparticles is in thin films that combine superior mechanical and electrical properties. For example, as part of touch screensin addition, polymer nanocomposites containing such nanoparticles can be used among other things in electromagnetic shielding and conductive films for packaging and high performance adhesives. These nanoparticles are expected to reveal interesting catalytic applications, for example to obtain sulfur free gasoline. They can be used in third generation photovoltaic cells, etc.

Applications


  • Catalytic processes for energy storage and sulfur free gasoline.
  • Polymer nanocomposites for packaging
  • Electromagnetic shielding.
  • Conductive glues/adhesives with superior performance.
  • Energy storage.

Advantages


The combination of superior mechanical properties and high electrical conductivity offers new kinds of applications in catalysis; energy storage; high performance nanocomposites and in macroelectronics.

 

+
  • Prof. Tenne Reshef
1498
MicroRNAs as potential biomarkers for ALS.Amyotrophic Lateral Sclerosis (ALS) is a devastating disease that progressively destroys motor neurons in the brain and the spinal cord, eventually causing paralysis and death. Currently, there are approximately 25,000 patients with ALS in the USA, with a...

MicroRNAs as potential biomarkers for ALS.
Amyotrophic Lateral Sclerosis (ALS) is a devastating disease that progressively destroys motor neurons in the brain and the spinal cord, eventually causing paralysis and death. Currently, there are approximately 25,000 patients with ALS in the USA, with a median age of onset of 55 years. Approximately 5–10% of patients with ALS have a family history, and these patients most frequently inherit the disease in an autosomal dominant manner. Family-based linkage studies have led to the identification of several genes for familial ALS. However these findings only explain a small fraction of all ALS cases. The majority of ALS cases have no obvious family history and are referred to as sporadic ALS. At present, there is no effective therapy for the disease and patients usually die within 2-5 years after the onset of symptoms. Thus, there is an urgent need for biomarkers that could substantially aid early diagnosis of ALS and will help in designing decisive clinical trials of new drugs. The present technology provides specific microRNAs that can serve as potential biomarkers for ALS.

Applications


  • Unique patterns of microRNA expression profile in the cerebrospinal fluid of ALS patients could be useful as molecular biomarkers for disease diagnosis and eventually prediction of therapeutic responses.
  • The suggested ALS biomarkers may be employed in drug development studies.

 


Advantages


  •  MicroRNAs can be precisely quantified using qRT-PCR that provides exceptionally high sensitivity and specificity of detection.
  • The small size of microRNAs offers a unique advantage since they are more stable and less prone to enzymatic degradation, and are therefore amenable to an accurate assessment of their expression levels.

Technology's Essence


MicroRNAs (miRNAs) are endogenous small noncoding RNAs that negatively regulate gene expression in a posttranscriptional fashion and contribute to a wide variety of biological processes. miRNAs play important roles in the development of the central nervous system and their involvement in neurodegenerative diseases such as Parkinson's disease and Alzheimer’s disease has been recently established. The outlined technology describes specific miRNAs that are enriched in motor neurons and are significantly downregulated in mouse models of hereditary motor neuron disease (SOD1G93A and SMN1). These miRNAs may serve as putative biomarkers for motor neuron diseases such as ALS by measurement of their expression levels in cerebrospinal fluid samples collected from affected individuals.

+
  • Dr. Eran Hornstein
1499
Bladder cancer is a common malignancy; it is the 4th most common cancer in males and the 9th in females.  The presenting symptom is usually blood in the urine, and diagnosis is currently based on cystoscopy, which is invasive, costly, painful and time consuming.  To date, no biomarker has been...

Bladder cancer is a common malignancy; it is the 4th most common cancer in males and the 9th in females.  The presenting symptom is usually blood in the urine, and diagnosis is currently based on cystoscopy, which is invasive, costly, painful and time consuming.  To date, no biomarker has been identified in the urine that might be used for screening, staging, prognosis and monitoring treatment.  We now report that the amount of the 60 kDa heat shock protein (HSP60) in a subject’s urine is a biomarker for muscle invasion in patients with bladder cancer – stage T2 and higher.  Moreover, subjects with stage T1 disease can be stratified by their urine levels of HSP60 into a sub-group likely to progress into stage T2 or into a sub-group more likely to respond to conservative treatment with BCG, which does not require removal of the bladder.  The distinction between these two sub-groups of T1 bladder cancer can identify earlier subjects in need of cystectomy, while sparing others unnecessary major surgery.

Applications


  • Screening subjects with overt hematuria, or at risk of developing bladder cancer (such as heavy smokers)
  • tratifying bladder cancer subjects
  • Prognosis
  • Determining treatment program
  • Monitoring response to therapy.

Advantages


  • Non-invasive
  • Easy to apply
  • Relatively inexpensive
  • Prognositic.

Technology's Essence


Quantitative measurement of HSP60 levels in a subject’s urine by ELISA, radio-immunoassay or other simple assays.

+
  • Prof. Irun R. Cohen
1503
Application of Ureides-class compounds protects plants from stress related senescence, effectively extending the shelf-life of vegetables, fruit, leafy greens, cut branches and flowers. Plants suffer damage from factors such as oxidative stress, premature senescence and chlorophyll degradation. All of...

Application of Ureides-class compounds protects plants from stress related senescence, effectively extending the shelf-life of vegetables, fruit, leafy greens, cut branches and flowers.

Plants suffer damage from factors such as oxidative stress, premature senescence and chlorophyll degradation. All of the above can impact the freshness of produce from harvest to end-consumer. Researchers at the Weizmann Institute found that under certain stress conditions model plants produce Ureides, shown to have a protective role. Unexpectedly, this protection can also be achieved by the exogenous application to plants or plant parts post-harvest.

This innovative technique to preserve and prolong the shelf-life of fresh produce is clean, organic and cost-effective. In addition, engineered strains with altered Ureides metabolism can prove more resistant to stress related senescence.

Applications


  • Post-harvest protection of produce via
  • Exogenous application (spray on leaves, add to roots etc.).
  • Incorporation in packaging (e.g. embedded in plastic film).

Advantages


  • Treatment of both aging and light-deprivation in plants
  • Readily available and easily applied, does not require expertise to protect produce
  • Organic, clean, biodegradable materials.

Technology's Essence


Prof. Robert Fluhr and his team found that in wild-type plants conditions of extended darkness or increasing leaf age caused induction of transcripts related to purine catabolism, resulting in marked accumulation of Ureides. In contrast, Arabidopsis mutants of XDH, Atxdh1, accumulated the Ureides precursor (Xanthine) and showed premature senescence symptoms such as enhanced chlorophyll degradation, extensive cell death and upregulation of senescence-related transcripts.

The level of plant reactive oxygen species (ROS) and mortality can be attenuated by the addition of Ureides, suggesting that these metabolites can act as scavengers of ROS. The results highlighted that the regulation of Ureides levels by Atxdh1 has implications for optimal plant survival during nutrient remobilization, such as occurs during normal growth, dark stress and senescence.

+
  • Prof. Robert Fluhr
1506
A simple electrochemical method and apparatus for the continues production of CO (carbon monoxide) from CO2 as chemical storage for electrical energy and a basic material for further organic products. Constant progress is made in solar and wind alternative energy production. Unfortunately, these...

A simple electrochemical method and apparatus for the continues production of CO (carbon monoxide) from CO2 as chemical storage for electrical energy and a basic material for further organic products.

Constant progress is made in solar and wind alternative energy production. Unfortunately, these systems are weather and time-dependent. Additionally, most of the geographic areas best suited for harvesting these resources are remote from population centers. Therefore the need for a reliable method to store and transport renewable energy is clear.

CO can be easily converted into methanol, which is one of the major chemical raw materials and can by itself be used as fuel for diesel engines and the energy source for direct methanol fuel cells (DMFC).

At present no reliable method of CO2 to CO reduction is available. Either using low temperatures which leads to low thermodynamic efficiency (<60%), Requires precious metals for electrodes and results in toxic byproducts, or using high temperatures which Requires pure CO2 input and Produces a mixture of CO2 and CO.

The current technology describes an efficient, flexible, continues method for production of CO at high temperatures (900oC) without any byproducts or toxic materials.

Applications


  • Production of CO from CO2
  • Easy conversion into methanol

Advantages


·         No precious (Pt, Ag, Au, Pd) metals required

·         No hazardous chemicals involved, no pollution

·         Continuous operation is possible

·         One can use flue gas as a source

·         Capture of CO2 from air is possible

·         The system is very compact>20 kW/m3

·         Operation conditions are very flexible

·         The process fits existing infrastructure

·         CO can be easily converted into liquid fuel (CH3OH)


Technology's Essence


The outlined technology overcomes the basic problems of CO production by using molten Li2CO3 as the electrolyte, a Ti container (will not undergo corrosion), Ti cathode (does not catalyze decomposition of CO), and a graphite anode (no chemical reaction with Li2CO3). At 900°C and current density of 0.05-2 A/cm2, this unique system enables a thermodynamic efficiency close to 100%, continues production of CO – efficiently separating CO2 to CO and O2.

+
  • Prof. Igor Lubomirsky
1507
One-step synthesis of primary amines from alcohols and ammonia under mild conditions.Amines are widely used in the production of numerous products for multiple industries and their use is expected to increase. Global amines market is expected to reach over $14 billion by 2020, with an average annual...

One-step synthesis of primary amines from alcohols and ammonia under mild conditions.
Amines are widely used in the production of numerous products for multiple industries and their use is expected to increase. Global amines market is expected to reach over $14 billion by 2020, with an average annual growth of 3.5%.
Primary amines are most useful in the larger markets of ethanolamines and fatty amines.
Current synthetic methods require harsh reaction conditions, are non-specific and generate toxic waste. The outlined technology utilizes a novel catalyst to synthesize primary amines in a simple single-step fashion directly from alcohols and ammonia.

Applications


• Production of primary amines for numerous industries (agrochemicals, surfactants, personal care, water treatment, fine chemicals, plastics, dyes, pigments, food additives and pharmaceuticals)

Advantages


  • Mild reaction conditions
  • Single step synthesis
  • High yields
  • No solvent required
  • No toxic reagents or by-products
  • Ecologically and economically beneficial

Technology's Essence


Amines are a very important family of compounds used in multiple industries. The presented technology uses selective catalytic synthesis of primary amines from primary alcohols and ammonia. This simple, one-step, easily applicable reaction delivers primary amines in good yields, in addition to valuable environmental and economic advantages.

+
  • Prof. David Milstein
1518
Improved immunotherapy for breast cancer. Monoclonal antibodies (mAbs) to ErbB-2/HER2 growth factor receptor, or to its sibling, the epidermal growth factor receptor (EGFR), prolong survival of cancer patients, especially when combined with cytotoxic therapies. However, low effectiveness of...

Improved immunotherapy for breast cancer.

Monoclonal antibodies (mAbs) to ErbB-2/HER2 growth factor receptor, or to its sibling, the epidermal growth factor receptor (EGFR), prolong survival of cancer patients, especially when combined with cytotoxic therapies. However, low effectiveness of therapeutic mAbs and the evolution of patient resistance call for improvements. Furthermore, the response to the clinically approved monotherapy of Herceptin (a humanized mAb directed against ErbB-2), is relatively low (~15%) and short lived (median duration, 9 months). Therefore, there is a need to improve the therapeutic treatment against this receptor. The present technology enhances the therapeutic activity of anti-ErB-2 receptor antibodies, by combining two or more epitope-distinct antibodies.

Applications


  • Improved treatment of ErbB-2-overexpressing tumors (e.g. in breast and ovary cancers).


Advantages


  • May enhance patient response and delay acquisition of resistance.
  • Enhancement of therapeutic efficacy and synergy with chemotherapy.

Technology's Essence


Optimal selection of mAbs for cancer immunotherapy may improve its therapeutic potential. The outlined technology addresses an emerging strategy, which enhances the therapeutic activity of anti-receptor antibodies by combining two mAbs engaging distinct epitopes. It was demonstrated that pairs of anti-ErbB-2 mAbs better inhibit ErbB-2-overexpressing tumors than the respective individual mAbs, both in vitro and in vivo.

+
  • Prof. Yosef Yarden
1522
A method for enhancing the spatial and or temporal resolution (if applicable) of an input signal such as images and videos.   Many imaging devices produce signals of unsatisfactory resolution (e.g. a photo from a cell-phone camera may have low spatial resolution or a video from a web camera may have...

A method for enhancing the spatial and or temporal resolution (if applicable) of an input signal such as images and videos.

 

Many imaging devices produce signals of unsatisfactory resolution (e.g. a photo from a cell-phone camera may have low spatial resolution or a video from a web camera may have both spatial and temporal low resolution). This method applies digital processing to reconstruct more satisfactory high resolution signals.

 

Previous methods for Super-Resolution (SR) require multiple images of the same scene, or else an external database of examples. This method provides the ability to perform SR from a single image (or a single visual source). The algorithm exploits the inherent local data redundancy within visual signals (redundancy both within the same scale, and across different scales).

 

Examples of the methods' capabilities can be found here: http://www.wisdom.weizmann.ac.il/~vision/SingleImageSR.html

 

Applications


  • Enhancing the spatial resolution of images

  • Enhancing the spatial and or temporal resolution of video sequences

  • Enhancing the spatial and or temporal resolution (if applicable) of other signals (e.g., MRI, fMRI, ultrasound, possibly also audio, etc.)

 


Advantages


  • No need for multiple low resolution sources or the use of an external database of examples.

  • Superior results are produced due to exploitation of inherent information in the source signal.


Technology's Essence


The framework combines the power of classical multi image super resolution and example based super resolution. This combined framework can be applied to obtain super resolution from as little as a single low-resolution signal, without any additional external information. The approach is based on an observation that patches in a single natural signal tend to redundantly recur many times inside the signal, both within the same scale, as well as across different scales.

Recurrence of patches within the same scale (at subpixel misalignments) forms the basis for applying the 'classical super resolution' constraints to information from a single signal. Recurrence of patches across different (coarser) scales implicitly provides examples of low-resolution / high-resolution pairs of patches, thus giving rise to 'example-based super-resolution' from a single signal (but without any external database or any prior examples).

+
  • Prof. Michal Irani
1529
We present an efficient and robust broadband crystal optical conversion device. Various applications of laser optics require tunable laser sources. Currently, most frequency conversion devices rely on a single non-linear crystal, which is either temperature or angle tuned to enhance efficiency. This...

We present an efficient and robust broadband crystal optical conversion device. Various applications of laser optics require tunable laser sources. Currently, most frequency conversion devices rely on a single non-linear crystal, which is either temperature or angle tuned to enhance efficiency. This results only in a narrow efficient spectral band of conversion. Other techniques such as periodic quasi-phase matching result in improved efficiencies but still within a narrow predetermined band. Random quasi-phase matching results in improved bandwidth but in a significant reduction in efficiency. This new device enables ultra-broadband wavelength conversion while maintaining high efficiency.

Applications


  • Laser optics industry
  • Frequency convertor for broadband signals
  • Generation of ultrafast visible radiation
  • Pulse selection.

Advantages


  • 90% efficiency of conversion process.
  • Simple and compact
  • Insensitive to the deviations in alignment, no dependence of the angle incidence beam or of temperature
  • Frequency converter of both broadband signals and ultra-short pulses.

Technology's Essence


This device is based on a new method of adiabatic wavelength conversion. The device works whereby a strong narrow-band pump is introduced into the crystal along with a weaker pulse to be converted. This conversion is realized in a quasi-phase matched nonlinear crystal, where the period is tuned adiabatically from strong negative phase-mismatch to strong positive phase-mismatch (or vice versa). This results in the efficient transformation of the weaker pulse.

+
  • Prof. Yaron Silberberg
1536
Designer cellulosomes are synthetic multi-enzyme complexes that can degrade cellulosic biomass efficiently and economically. The goal of second generation biofuel production is to efficiently convert agricultural waste, algae and other cellulosic biomass into sugar monomers.   Cellulosic biomass...

Designer cellulosomes are synthetic multi-enzyme complexes that can degrade cellulosic biomass efficiently and economically. The goal of second generation biofuel production is to efficiently convert agricultural waste, algae and other cellulosic biomass into sugar monomers.

 

Cellulosic biomass pretreated (e.g. with acid) under ideal conditions, still requires very high enzyme doses to provide efficient bioconversion.

The cost of enzymes and pretreatment is a major hurdle in the production of low-cost cellulosic biofuel, competitive with that of fossil fuels or ethanol produced from corn or sugarcane.

 

The complex structure of cellulosic materials is built to resist bacterial hydrolytic enzymes. The cooperation of many types of carbohydrate-active enzymes is required for effective degradation. By designing synthetic cellulosomes, researchers at The Weizmann Institute enhance synergy between carbohydrate-active enzymes to achieve remarkable degradation rates. Their discoveries can lead to highly efficient conversion of cellulosic biomass, and thus have a major impact in the field of food production and sustainable energy.

Applications


  • High-yield, cost-effective conversion of plant cell wall biomass into soluble sugars for the food industry and the production of biofuels and biochemicals.

Advantages


  • Bio-engineered cellulosomes exhibit synergistic degradation activity of natural substrates compared to the combined action of the free wild-type enzymes.

Technology's Essence


The invention involves the conversion of enzymes (cellulases and xylanases) from the free mode to the cellulosmal mode by attachment using a recombinant dockerin molecule. The dockerin-bearing enzymes are incorporated into designer cellulosomes by interacting with a matching cohesion-containing chimeric scaffoldin (scaffoldin subunits contain the cohesin modules that incorporate the enzymes into the cellulosome complex via their resident dockerins). This approach has generated over two fold enhancement of synergistic hydrolysis on plant cell wall cellulosic biomass. These results create new possibilities for designing superior enzyme compositions for degradation of complex polysaccharides into simple soluble sugars.

+
  • Prof. Edward A. Bayer
1546
Improvement of protein production by modulating the tRNA pool. For maximal heterologous expression of proteins per host cell, the optimal level of expression of genes needs to be addressed. The science and art of expressing a gene from one species in another often amounts to modifying the codons of the...

Improvement of protein production by modulating the tRNA pool. For maximal heterologous expression of proteins per host cell, the optimal level of expression of genes needs to be addressed. The science and art of expressing a gene from one species in another often amounts to modifying the codons of the gene, and supplementing the host with specific tRNAs. Yet the full challenge of heterologous expression is not only to maximize expression per host cell, but also to minimize the burden on the host. The outlined invention describes a universally conserved profile of translation efficiency along mRNAs, based on the adaptation between coding sequences and the tRNA pool, to improve heterologous gene expression and thus protein production.

Applications


  • Improvement of the yield and success rate of recombinant protein production.

Advantages


  • Protein expression levels can be artificially increased
  • Minimization of the burden on the host

Technology's Essence


The translation efficiency profile of a gene is defined, for each codon position, as the estimated availability of the tRNAs that participate in translating that codon. The profile is high at codons that correspond to abundant tRNAs and low at codons that correspond to rare tRNAs. In this invention it is predicted that the first ~30-50 codons of genes appear to be translated with a low efficiency “ramp”, while the last ~50 codons show highest efficiency. The “ramp” serves as a late stage of initiation and is an optimal and robust means to reduce ribosomal traffic jams, thus minimizing occupation of free ribosomes, ribosomal abortions and, ultimately, the cost of protein expression. Implementation of appropriate ramping in heterlogous proteins, given the host?s tRNA pool, might improve the yield of expressed recombinant proteins.

+
  • Prof. Yitzhak Pilpel
1549
A tailor-made strategy for cancer treatment. The ErbB family of tyrosine kinase receptors and their ligands play important roles in development and tissue remodeling throughout adulthood. ErbB proteins are involved in several types of human cancer. Clinical studies indicate that over-expression of one...

A tailor-made strategy for cancer treatment. The ErbB family of tyrosine kinase receptors and their ligands play important roles in development and tissue remodeling throughout adulthood. ErbB proteins are involved in several types of human cancer. Clinical studies indicate that over-expression of one or more ErbB ligands correlates with decreased patient survival. The currently approved drugs for the treatment of cancers driven by the ErbB family target the receptors rather than the ligands, and they include either monoclonal anti-receptor antibodies, or tyrosine kinase inhibitors (TKIs). Because of resistance and moderate clinical efficacies of anti-receptor antibodies and TKIs it is worthwhile considering alternative strategies. The present technology combines several antibodies, capable of blocking ErbB ligands, with chemotherapy.

Applications


  • Treatment of cancers that possess the ErbB receptors (e.g. colorectal, liver, bladder, and head and neck tumors)

Advantages


  • Effective blockade of the tumorigenic action of ErbB-specific ligands
  • The combination protocol may enhance the sensitivity to chemotherapy

Technology's Essence


In the outlined technology, monoclonal antibodies were generated against two ligands, namely TGF-? and heparin-binding EGF-like growth factor. Combining the two antibodies with a chemotherapeutic drug enhanced the ability of chemotherapy to inhibit pancreatic tumors in mice. Therefore, this technology offers a general cancer therapeutic strategy that entails profiling the repertoire of growth factors secreted by a tumor, and combining with chemotherapy several antibodies capable of blocking autocrine ligands, in a way that sensitizes tumors to cytotoxicity and delays onset of chemoresistance.

+
  • Prof. Yosef Yarden
1551
A novel set of manganese, ruthenium and related borohydride complexes (Pincer-type) were developed as remarkably efficient and environmentally-benign catalysts for the synthesis of alcohols, amines, amides, imines and esters, which are the basic building blocks for the research, chemicals,...

A novel set of manganese, ruthenium and related borohydride complexes (Pincer-type) were developed as remarkably efficient and environmentally-benign catalysts for the synthesis of alcohols, amines, amides, imines and esters, which are the basic building blocks for the research, chemicals, pharmaceutical and agrochemical industries. In addition, a catalytic carbon-carbon bond formation using non-activated aliphatic nitriles and carbonyl compounds was achieved with the manganese complex. These reactions are conducted under mild and neutral conditions, using low catalyst loading, require no hydrogen acceptors or oxidants, employ no corrosive or toxic reagents and generate no waste. Moreover, manganese is one of the most abundant transition metals on earth crust, making it appealing and biocompatible when considering a system for eventual scale-up and industrial use.

In view of global concerns regarding economy, environment and sustainable energy resources, there is an urgent need for the discovery of new catalytic reactions. These newly developed catalysts address key problems of current traditional synthetic methodologies, both from the economic and the environmental aspects.

Applications


·         Pharmaceuticals

·         Dyes

·         Cosmetics and fragrances

·         Fibers

·         Agrochemicals


Advantages


·         Cost-effective in terms of reagents, reactions conditions (low temperature and pressure) and waste treatment (green reactions).

·         New synthetic pathways that were not possible before, such as the synthesis of amides and imines directly from alcohols and amines, esters synthesis from alcohols and methanol synthesis from CO2 and hydrogen.

·         Broad substrate scope.

·         Excellent yields.


Technology's Essence


Prof. David Milstein’s group has discovered a new mode of action for metal-ligand cooperation, involving aromatization–dearomatization of ligands. Pincer-type, pyridine-based complexes of Mn, Ir, Rh, Ru, Pd, Pt and acridine complexes of Ru have been shown to exhibit such cooperation, leading to facile activation of C-H, C-C, H-H, N-H, O-H bonds, and to novel, environmentally friendly reactions catalyzed by Mn and Ru.

+
  • Prof. David Milstein
1554
We present a novel approach resulting in efficient and robust wireless energy transfer in the mid-range. Applications of wireless energy transfer are already in use and are continuously being developed. The main limit of wireless energy transfer techniques is that both the transmitter and transformer...

We present a novel approach resulting in efficient and robust wireless energy transfer in the mid-range. Applications of wireless energy transfer are already in use and are continuously being developed. The main limit of wireless energy transfer techniques is that both the transmitter and transformer need to be of the same resonance. In addition, this technique is very susceptible to noise which limits efficiency. The present invention provides a technique for a robust and efficient mid-range wireless power transfer between two coils. This technique can transfer the energy between the coils without being sensitive to any resonant constrains, noise and other interferences that exist in the neighborhood of the coils

Applications


  • Simultaneous energy transfer to several electrical gadgets.

Advantages


  • Efficient
  • Not sensitive to electrical interference.
  • No need for an exact resonance match between transmitter and transformer.

Technology's Essence


The efficiency and robustness of this technology is achieved by adapting the process of rapid adiabatic passage (RAP) for a coherently driven two state atom to the field of wireless energy transfer. In other words, the resonance of the transmitter is tuned adiabatically to scan a resonant frequency range, thus arriving at a dynamic solution to the electrical transfer problem.

+
  • Prof. Yaron Silberberg
1555
Albumin binding probe for extending the lifetime of drugs. Most polypeptide drugs, in particular non-glycosylated proteins of molecular mass less than 50 kDa, are short-lived species in vivo having circulatory half lives of 5-20 min. Drug association with endogenous albumin may be suitable for...

Albumin binding probe for extending the lifetime of drugs. Most polypeptide drugs, in particular non-glycosylated proteins of molecular mass less than 50 kDa, are short-lived species in vivo having circulatory half lives of 5-20 min. Drug association with endogenous albumin may be suitable for designing an approach to protract the action in vivo of, potentially, any short-lived peptide/protein drug. In doing so two principal obstacles must be overcome: (1) following its conjugation, the probe introduced into a peptide or a protein should have sufficient affinity to albumin to manifest prolonged action in vivo, and (2) in case such covalent introduction results in an inactive product, the latter should be capable to undergo slow reactivation at physiological conditions. The present invention relates to engineering prolonged-acting prodrugs employing an albumin-binding probe that undergoes slow hydrolysis at physiological conditions.

Applications


  • Prolonging half life of short-lined drugs

Advantages


  • Prolonging the action of the drug without effecting its activity 
  • A desirable pharmacokinetic pattern

Technology's Essence


Since albumin is long-lived in vivo, drugs and endogenous substances that tightly associate with it have lower clearance rates than that of the unbound substances, and exhibit prolonged lifetime profiles in vivo. The present invention is based on a concept according to which a long chain fatty acid (LCFA) like albuminbinding compound is covalently linked to a short-lived amino-containing drug to form a non-covalent drug conjugate capable of associating with albumin in vivo, i.e., a long-lived prodrug that gradually releases the pharmacologically active constituent. This approach has been successfully implemented with several drugs (e.g. insulin, exendin and gentamicin).

+
  • Prof. Matityahu Fridkin
  • Prof. Yoram Shechter

Pages